CooperR.SchrigerD. (2005). The availability of references and the sponsorship of original research cited by pharmaceutical advertisements. Canadian Medical Association Journal, 172, 487-491.
2.
Fugh-BermanA.AlladinK.ChowJ. (2006). Advertising in medical journals: Should current practices change?PLoS Medicine, 3, e130. doi:10.1371/journal.pmed.003013010.1371/journal.pmed.0030130
International Committee of Medical Journal Editors. (n.d.). Uniform requirements for manuscripts submitted to biomedical journals: Publishing and editorial issues related to publication in biomedical journals: Advertising. Retrieved from http://www.icmje.org/publishing_8advertising.html
5.
KesslerD.PinesW. (1990). The federal regulation of prescription drug advertising and promotion. Journal of the American Medical Association, 264, 2409-2415.
6.
KorensteinD.KeyhaniS.MendelsonA.RossJ. (2011). Adherence to pharmaceutical advertisements in medical journals to FDA guidelines and content for safe prescribing. PLoS One, 6, 2-7.
7.
OthmanN.VitryA.RougheadE. (2009). Quality of pharmaceutical advertisements in medical journals: A systematic review. PLoS One, 4, e6350. doi:10.1371/journaql.pne.000635010.1371/journaql.pne.0006350
8.
SpielmansG.ThielgesS.DentA.GreenbergR. (2008). The accuracy of psychiatric medication advertisements in medical journals. Journal of Nervous and Mental Disease, 196, 267-273.